Coronary heart disease death
2 papers
- Humans2
Latest
7 in 12 monthsJACC Cardiovascular Imaging
Incremental Predictive Value of Deep Learning-Quantified Coronary Atherosclerotic Volume: A SCAPIS Cohort Analysis
Cohort study of 23,314 peopleBiomarkers
Journal of the American College of Cardiology
Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study
Randomised trial in 12,257 peopleEvolocumab
Annals of Internal Medicine
Longitudinal Changes in Heart Stress and the Risk for Cardiovascular Disease and Mortality in Older Adults : An Observational Study
Cohort study of 8,454 peopleCardiovascular disease
ADA Scientific Sessions 2026 Abstract
Evolocumab Reduces CV Events in Patients with High-Risk Diabetes: Results from the VESALIUS-CV Trial
Randomised trial in 12,257 peopleEvolocumab
AHA Scientific Sessions 2025 Abstract
Prediabetes, Obesity and Risk of Cardiovascular Disease among 1.3 million Patients from an Integrated Health Care System
Cohort study in peopleAtherosclerotic cardiovascular disease
AHA Scientific Sessions 2025 Abstract
Comparative evaluation of a proteomic cardiovascular risk assessment tool to coronary artery calcium score
Cohort study of 2,122 peopleCoronary artery calcium score
AHA Scientific Sessions 2025 Abstract
Enhancing the PREVENT Equation with a Polygenic Risk Score: Clinical Utility Evaluation
Cohort study of 60,544 peoplePREVENT equations
BMJ
Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis
Meta-analysis of observational studiesCardiovascular disease
European Heart Journal
Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin
Computational studyAtorvastatin
Diabetes Care
Insulin resistance syndrome predicts coronary heart disease events in elderly type 2 diabetic men
Cohort study of 229 peopleCoronary heart disease